Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gene therapy
Biotech
Gene editor shelves sole clinical asset, lays off 25% of staff
Despite hitting a clinical “milestone,” Prime Medicine is shelving its sole clinical-stage genetic medicine.
Gabrielle Masson
May 19, 2025 2:28pm
Atsena gene therapy hits safety goals, closes retinal splits
May 19, 2025 12:59pm
Neurogene details death in Rett syndrome gene therapy trial
May 16, 2025 3:00pm
Rocket's gene therapy sets new efficacy bar in ph. 1 heart study
May 16, 2025 10:36am
Beacon shines a light on positive early data from eye disease ph. 2
May 7, 2025 7:15am
J&J gene therapy fails ph. 3 rare eye disease trial
May 5, 2025 11:33am
